CytomX Therapeutics

CytomX Therapeutics is a clinical-stage biopharmaceutical company focused on revolutionizing cancer treatment with its innovative Probody® platform. Their unique approach involves masking potent anti-cancer medications, limiting their activity in healthy tissues and enhancing their potency within the tumor microenvironment. This technology holds the potential to create safer and more effective therapies, expanding the therapeutic window for existing drugs and unlocking the potential of previously "undruggable" targets.

CytomX is actively advancing a pipeline of Probody therapeutics across various modalities, including antibody-drug conjugates (ADCs), T-cell-engaging bispecifics (TCBs), and cytokine therapy. They are committed to partnering with leading pharmaceutical companies to maximize the impact of their platform and bring these potentially life-changing therapies to patients as quickly as possible. Their focus on innovation, partnership, and a mission-driven culture positions them as a leader in the evolving field of conditionally activated cancer therapies.

CytomX Therapeutics offers a competitive total rewards program that includes flexible spending coverage and paid time off, though specific details about other forms of job flexibility, such as remote work options or flexible scheduling, are not mentioned on their website.

CytomX Therapeutics offers a competitive total rewards program that includes a variety of healthcare programs, income protection coverage, tax savings with 401(k) programs, and flexible spending coverage. Their compensation programs include equity, annual incentives, and paid time off.

CytomX Therapeutics is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer therapies using their proprietary Probody® platform. Their mission is to revolutionize cancer treatment by urgently advancing their pipeline of Probody® therapeutics, which are designed to be safer, more effective, and potentially life-changing for patients.

CytomX Therapeutics fosters a collaborative and innovative culture that prioritizes integrity, commitment, creativity, teamwork, accountability, and fun. They actively seek to enhance and maintain a culture of equity and inclusion, encouraging individuals to be themselves and feel respected and connected. CytomX believes that diverse ideas and experiences contribute to the company's success and embraces change to achieve both corporate and individual objectives.

CytomX Therapeutics is committed to fostering a culture of diversity, equity, and inclusion. They believe that a diverse workforce benefits from a variety of ideas and experiences, and strive to create an environment where everyone feels included, respected, and connected. They recognize that DEI initiatives require ongoing commitment and are committed to creating a welcoming and inclusive workplace for all. This applies to their internal work environment, how they work with external parties, how they represent themselves in their community, and how they endeavor to bring their innovations to a diverse patient population.